Owlstone Medical Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Owlstone Medical Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6516
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detection; and ATLAS for volatile organic compounds sampling from clinical sample. Owlstone Medical provides UltraFAIMS for enhanced mass spectrometry for medical research; simulated human breath (SiHuB) products; CASPER that provides clean air supply for portable use in clinics; and respiration collector for in vitro analysis (ReCIVA) breath sampler. The company’s products are used in applications such as lung cancer, asthma, tuberculosis, bowel (colorectal) cancer, coeliac disease and irritable bowel syndrome, inflammatory bowel disease, bile acid diarrhea, gastrointestinal toxicity, drug metabolites in urine, and propofol detection and monitoring. It operates offices in Cambridge and London, the UK. Owlstone Medical is headquartered in London, the UK.

Owlstone Medical Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Owlstone Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Owlstone Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Owlstone Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Owlstone Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Owlstone Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Owlstone Medical Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Owlstone Medical Raises Additional USD35 Million in Venture Financing 10
Owlstone Medical Raises USD15 Million in Venture Financing 11
Owlstone Medical Raises Funds through Venture Financing 12
Owlstone Medical Raises USD11.5 Million in Financing Round 13
Partnerships 14
Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline 14
Owlstone Medical Enters into Agreement with Cancer Research UK 15
Owlstone Medical Enters into Agreement with Imperial College London 16
Equity Offering 17
Owlstone Medical Raises USD7 Million in Financing 17
Owlstone Medical Ltd – Key Competitors 18
Owlstone Medical Ltd – Key Employees 19
Owlstone Medical Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Oct 10, 2018: Owlstone Medical appoints Dr Richard A Yost to Scientific Advisory Board 21
Sep 13, 2018: Owlstone Medical names Dr Andy Richards CBE as Board Director 22
Jul 19, 2018: Owlstone Medical appoints five leading experts to scientific advisory board 23
May 23, 2017: Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder 26
Mar 24, 2017: Owlstone Medical Wins Business Innovation Award for Breath Biopsy Technology 27
Product News 28
Mar 28, 2018: Owlstone Medical Launches Breath Biopsy Kits 28
Dec 05, 2017: Owlstone Medical Selected to Participate at Upcoming Cavendish Global Health Impact Forum 29
Apr 19, 2017: Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy 30
Other Significant Developments 31
Apr 09, 2018: Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD 31
Mar 07, 2017: Owlstone Medical to Provide Breath Biomarker Services for 4D Pharma Using Breath Biopsy Platform 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Owlstone Medical Ltd, Medical Equipment, Key Facts, 2017 2
Owlstone Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Owlstone Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Owlstone Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Owlstone Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Owlstone Medical Ltd, Deals By Market, 2012 to YTD 2018 8
Owlstone Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Owlstone Medical Raises Additional USD35 Million in Venture Financing 10
Owlstone Medical Raises USD15 Million in Venture Financing 11
Owlstone Medical Raises Funds through Venture Financing 12
Owlstone Medical Raises USD11.5 Million in Financing Round 13
Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline 14
Owlstone Medical Enters into Agreement with Cancer Research UK 15
Owlstone Medical Enters into Agreement with Imperial College London 16
Owlstone Medical Raises USD7 Million in Financing 17
Owlstone Medical Ltd, Key Competitors 18
Owlstone Medical Ltd, Key Employees 19
Owlstone Medical Ltd, Other Locations 20

List of Figures
Owlstone Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Owlstone Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Owlstone Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Owlstone Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Owlstone Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Owlstone Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Owlstone Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Owlstone Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Owlstone Medical Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trelleborg AB:企業の戦略・SWOT・財務情報
    Trelleborg AB - Strategy, SWOT and Corporate Finance Report Summary Trelleborg AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alucon Public Company Limited:戦略・SWOT・企業財務分析
    Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Alucon Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Quantum Utility Generation LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Utility Generation LLC (QUG) is an electric utility that acquires, develops, operates and optimizes power generation assets in the Americas. The utility generates electricity from various sources such as wind, coal and natural gas-based power generation plants. It also produces elect …
  • Lincoln National Corporation (LNC):企業の財務・戦略的SWOT分析
    Lincoln National Corporation (LNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Allegra Orthopaedics Ltd (AMT):医療機器:M&Aディール及び事業提携情報
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • AnaBios Corp-製薬・医療分野:企業M&A・提携分析
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization which carries out drug efficacy studies on human samples. Its products portfolio includes human dorsal root ganglia (hDRG) neuron cultures, human heart tissue samples,human cardiac mesenchymal stem cells, human bra …
  • China Gas Holdings Ltd (384):企業の財務・戦略的SWOT分析
    China Gas Holdings Ltd (384) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Atos SE:企業のM&A・事業提携・投資動向
    Atos SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atos SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向
    Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • China Petroleum & Chemical Corp (600028):石油・ガス:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Penn Virginia Corp (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • The Bank of Iwate Ltd:企業の戦略・SWOT・財務情報
    The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Po Valley Energy Ltd (PVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Po Valley Energy Ltd (Po Valley Energy) is an oil and gas company that offers exploration and development of hydrocarbon assets. The company's projects include Sillaro, Castello or Bezzecca, Sant'Alberto, Teodorico and Selva. Its Sillaro field is located in the province of Bologna with seven …
  • Anhui Construction Engineering Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Scorpio Tankers Inc. (STNG):企業の財務・戦略的SWOT分析
    Scorpio Tankers Inc. (STNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • National Cancer Centre Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Centre Singapore (NCCS) is a cancer research centre that offers research, education, clinical services, and patient care services. The centre offers services such as medical oncology, oncologic imaging, palliative medicine, pharmacy, psychosocial oncology, public education, r …
  • ImaginAb Inc:医療機器:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆